SK Biopharm, 381,273 Shares Net Bought by Individuals Over Last 5 Days... Stock Price 106,000 KRW (+0.95%)

As of 9:30 AM on the 24th, SK Biopharm is trading at 106,000 KRW, up 0.95% from the previous day. The trading volume is 49,735 shares, which is about 17.25% of the previous day's volume.

On March 23, researcher Gu Jayong from DB Financial Investment stated, "The initial sales performance of the new drug launched by SK Biopharm should be viewed with expectations rather than disappointment. Considering the characteristics of CNS (central nervous system) drugs, the initial sales of Xcopri have exceeded expectations even amid the COVID-19 situation. SK Biopharm, which has succeeded in new drug development and is building a global value chain, is becoming closer to UCB (a Belgium-based pharmaceutical company focused on CNS) rather than a simple bio company. Both earnings and stock price are expected to trend upward. Do not miss the current lowest point since listing." He set SK Biopharm’s target price at 140,000 KRW.

Over the past five days, individual investors have net purchased 381,273 shares of SK Biopharm, while foreigners and institutions have net sold 333,983 shares and 45,189 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.